O	O	0	10	Activation	Activation	B-NP	NN	O	14	SUB	O
O	O	11	13	of	of	B-PP	IN	O	1	NMOD	O
O	O	14	21	primary	primary	B-NP	JJ	B-cell_type	7	NMOD	B-cell_type
O	O	22	27	human	human	I-NP	JJ	I-cell_type	7	NMOD	I-cell_type
O	O	28	29	T	T	I-NP	NN	I-cell_type	7	NMOD	I-cell_type
O	O	29	30	-	-	O	HYPH	I-cell_type	7	NMOD	I-cell_type
O	O	30	41	lymphocytes	lymphocyte	B-NP	NNS	I-cell_type	2	PMOD	I-cell_type
O	O	42	49	through	through	B-PP	IN	O	1	NMOD	O
T1	B-Protein	50	53	CD2	CD2	B-NP	NN	B-protein	11	NMOD	B-protein
O	O	54	58	plus	plus	O	CC	I-protein	11	NMOD	I-protein
T2	B-Protein	59	63	CD28	CD28	B-NP	NN	I-protein	13	NMOD	I-protein
O	O	64	72	adhesion	adhesion	I-NP	NN	I-protein	13	NMOD	I-protein
O	O	73	82	molecules	molecule	I-NP	NNS	I-protein	8	PMOD	I-protein
O	O	83	90	induces	induce	B-VP	VBZ	O	0	ROOT	O
O	O	91	95	long	long	B-NP	JJ	O	19	NMOD	O
O	O	95	96	-	-	I-NP	HYPH	O	19	NMOD	O
O	O	96	100	term	term	I-NP	NN	O	19	NMOD	O
O	O	101	108	nuclear	nuclear	I-NP	JJ	O	19	NMOD	O
O	O	109	119	expression	expression	I-NP	NN	O	14	OBJ	O
O	O	120	122	of	of	B-PP	IN	O	19	NMOD	O
O	O	123	125	NF	NF	B-NP	NN	B-protein	24	NMOD	B-protein
O	O	125	126	-	-	B-NP	HYPH	I-protein	24	NMOD	I-protein
O	O	126	131	kappa	kappa	I-NP	NN	I-protein	24	NMOD	I-protein
O	O	132	133	B	B	I-NP	NN	I-protein	20	PMOD	I-protein
O	O	133	134	.	.	O	.	O	14	P	O

O	O	136	147	Stimulation	Stimulation	B-NP	NN	O	15	SUB	O
O	O	148	150	of	of	B-PP	IN	O	1	NMOD	O
O	O	151	157	highly	highly	B-NP	RB	B-cell_type	4	AMOD	B-cell_type
O	O	158	166	purified	purify	I-NP	VBN	I-cell_type	8	NMOD	I-cell_type
O	O	167	172	human	human	I-NP	JJ	I-cell_type	8	NMOD	I-cell_type
O	O	173	174	T	T	I-NP	NN	I-cell_type	8	NMOD	I-cell_type
O	O	174	175	-	-	I-NP	HYPH	I-cell_type	8	NMOD	I-cell_type
O	O	175	180	cells	cell	I-NP	NNS	I-cell_type	2	PMOD	I-cell_type
O	O	181	184	via	via	B-PP	IN	O	1	NMOD	O
T3	B-Protein	185	188	CD2	CD2	B-NP	NN	B-protein	12	NMOD	B-protein
O	O	189	192	and	and	I-NP	CC	O	12	NMOD	O
T4	B-Protein	193	197	CD28	CD28	I-NP	NN	B-protein	14	NMOD	B-protein
O	O	198	206	adhesion	adhesion	I-NP	NN	B-protein	14	NMOD	B-protein
O	O	207	216	molecules	molecule	I-NP	NNS	I-protein	9	PMOD	I-protein
O	O	217	224	induces	induce	B-VP	VBZ	O	0	ROOT	O
O	O	225	228	and	and	I-VP	CC	O	15	VMOD	O
O	O	229	238	maintains	maintain	I-VP	VBZ	O	15	VMOD	O
O	O	239	252	proliferation	proliferation	B-NP	NN	O	15	VMOD	O
O	O	253	256	for	for	B-PP	IN	O	15	VMOD	O
O	O	257	261	more	more	B-NP	JJR	O	21	AMOD	O
O	O	262	266	than	than	I-NP	IN	O	23	NMOD	O
O	O	267	268	3	3	I-NP	CD	O	21	AMOD	O
O	O	269	274	weeks	week	I-NP	NNS	O	19	PMOD	O
O	O	274	275	.	.	O	.	O	15	P	O

O	O	276	280	This	This	B-NP	DT	O	12	NMOD	O
O	O	281	287	potent	potent	I-NP	JJ	O	12	NMOD	O
T5	B-Protein	288	299	interleukin	interleukin	I-NP	NN	B-protein	12	NMOD	B-protein
T5	I-Protein	300	301	2	2	I-NP	CD	I-protein	3	NMOD	I-protein
O	O	302	303	(	(	O	(	O	9	DEP	O
T6	B-Protein	303	305	IL	IL	B-NP	NN	B-protein	7	NMOD	B-protein
T6	I-Protein	305	306	-	-	B-NP	HYPH	I-protein	9	DEP	I-protein
T6	I-Protein	306	307	2	2	I-NP	CD	I-protein	7	NMOD	I-protein
O	O	307	308	)	)	O	)	O	3	NMOD	O
O	O	308	309	-	-	B-NP	HYPH	O	12	NMOD	O
O	O	309	318	dependent	dependent	I-NP	JJ	O	12	NMOD	O
O	O	319	329	activation	activation	I-NP	NN	O	13	SUB	O
O	O	330	334	does	do	B-VP	VBZ	O	0	ROOT	O
O	O	335	338	not	not	I-VP	RB	O	13	VMOD	O
O	O	339	346	require	require	I-VP	VB	O	13	VC	O
O	O	347	356	monocytes	monocyte	B-NP	NNS	B-cell_type	19	NMOD	B-cell_type
O	O	357	359	or	or	O	CC	O	19	NMOD	O
O	O	360	369	accessory	accessory	B-NP	JJ	B-cell_type	19	NMOD	B-cell_type
O	O	370	375	cells	cell	I-NP	NNS	I-cell_type	15	OBJ	I-cell_type
O	O	375	376	.	.	O	.	O	13	P	O

O	O	377	381	Long	Long	B-NP	JJ	O	3	AMOD	O
O	O	381	382	-	-	I-NP	HYPH	O	1	P	O
O	O	382	389	lasting	last	I-NP	VBG	O	7	NMOD	O
T7	B-Protein	390	392	IL	IL	I-NP	NN	B-protein	7	NMOD	B-protein
T7	I-Protein	392	393	-	-	I-NP	HYPH	I-protein	7	NMOD	I-protein
T7	I-Protein	393	394	2	2	I-NP	CD	I-protein	7	NMOD	I-protein
O	O	395	406	receptivity	receptivity	I-NP	NN	O	8	SUB	O
O	O	407	409	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	410	420	associated	associate	I-VP	VBN	O	8	VC	O
O	O	421	425	with	with	B-PP	IN	O	9	VMOD	O
O	O	426	430	high	high	B-NP	JJ	O	14	NMOD	O
O	O	430	431	-	-	I-NP	HYPH	O	14	NMOD	O
O	O	431	436	level	level	I-NP	NN	O	14	NMOD	O
O	O	437	447	expression	expression	I-NP	NN	O	10	PMOD	O
O	O	448	450	of	of	B-PP	IN	O	14	NMOD	O
O	O	451	454	the	the	B-NP	DT	O	23	NMOD	O
O	O	455	464	inducible	inducible	I-NP	JJ	B-DNA	23	NMOD	B-DNA
T8	B-Protein	465	467	IL	IL	I-NP	NN	I-DNA	23	NMOD	I-DNA
T8	I-Protein	467	468	-	-	B-NP	HYPH	I-DNA	23	P	I-DNA
T8	I-Protein	468	469	2	2	I-NP	CD	I-DNA	23	NMOD	I-DNA
T8	I-Protein	470	478	receptor	receptor	I-NP	NN	I-DNA	23	NMOD	I-DNA
T8	I-Protein	479	484	alpha	alpha	I-NP	NN	I-DNA	23	NMOD	I-DNA
T8	I-Protein	485	490	chain	chain	I-NP	NN	I-DNA	30	NMOD	I-DNA
O	O	491	492	(	(	O	(	I-DNA	30	NMOD	I-DNA
T9	B-Protein	492	494	IL	IL	B-NP	NN	I-DNA	30	NMOD	I-DNA
T9	I-Protein	494	495	-	-	B-NP	HYPH	I-DNA	30	NMOD	I-DNA
T9	I-Protein	495	497	2R	2R	I-NP	NN	I-DNA	30	NMOD	I-DNA
T9	I-Protein	498	503	alpha	alpha	I-NP	NN	I-DNA	30	NMOD	I-DNA
O	O	503	504	)	)	O	)	I-DNA	30	NMOD	I-DNA
O	O	505	509	gene	gene	B-NP	NN	I-DNA	15	PMOD	I-DNA
O	O	510	514	that	that	B-NP	WDT	O	30	NMOD	O
O	O	515	517	is	be	B-VP	VBZ	O	31	SBAR	O
O	O	518	527	regulated	regulate	I-VP	VBN	O	32	VC	O
O	O	528	530	at	at	B-PP	IN	O	33	VMOD	O
O	O	531	535	both	both	B-NP	CC	O	38	AMOD	O
O	O	536	551	transcriptional	transcriptional	I-NP	JJ	O	38	AMOD	O
O	O	552	555	and	and	I-NP	CC	O	38	AMOD	O
O	O	556	575	posttranscriptional	posttranscriptional	I-NP	JJ	O	39	NMOD	O
O	O	576	582	levels	level	I-NP	NNS	O	34	PMOD	O
O	O	582	583	.	.	O	.	O	8	P	O

O	O	584	592	Increase	Increase	B-NP	NN	O	9	SUB	O
O	O	593	595	of	of	B-PP	IN	O	1	NMOD	O
T10	B-Protein	596	598	IL	IL	B-NP	NN	B-DNA	8	NMOD	B-DNA
T10	I-Protein	598	599	-	-	B-NP	HYPH	I-DNA	8	NMOD	I-DNA
T10	I-Protein	599	601	2R	2R	I-NP	NN	I-DNA	7	NMOD	I-DNA
T10	I-Protein	602	607	alpha	alpha	I-NP	NN	I-DNA	7	NMOD	I-DNA
O	O	608	612	gene	gene	I-NP	NN	I-DNA	8	NMOD	I-DNA
O	O	613	626	transcription	transcription	I-NP	NN	O	2	PMOD	O
O	O	627	635	involves	involve	B-VP	VBZ	O	0	ROOT	O
O	O	636	639	the	the	B-NP	DT	O	12	NMOD	O
O	O	640	648	enhanced	enhance	I-NP	VBN	O	12	NMOD	O
O	O	649	656	binding	binding	I-NP	NN	O	9	OBJ	O
O	O	657	659	of	of	B-PP	IN	O	12	NMOD	O
O	O	660	663	the	the	B-NP	DT	O	16	NMOD	O
O	O	664	677	transcription	transcription	I-NP	NN	B-protein	16	NMOD	B-protein
O	O	678	684	factor	factor	I-NP	NN	I-protein	20	NMOD	I-protein
T29	B-Entity	685	687	NF	NF	I-NP	NN	B-protein	20	NMOD	B-protein
T29	I-Entity	687	688	-	-	B-NP	HYPH	I-protein	20	NMOD	I-protein
T29	I-Entity	688	693	kappa	kappa	I-NP	NN	I-protein	20	NMOD	I-protein
T29	I-Entity	694	695	B	B	I-NP	NN	I-protein	13	PMOD	I-protein
O	O	696	698	to	to	B-PP	TO	O	12	NMOD	O
O	O	699	702	its	its	B-NP	PRP$	O	24	NMOD	O
T30	B-Entity	703	712	consensus	consensus	I-NP	NN	B-DNA	24	NMOD	B-DNA
T30	I-Entity	713	721	sequence	sequence	I-NP	NN	I-DNA	21	PMOD	I-DNA
O	O	722	724	in	in	B-PP	IN	O	24	NMOD	O
O	O	725	728	the	the	B-NP	DT	O	31	NMOD	O
T31	B-Entity	729	730	5	5	I-NP	CD	B-DNA	31	NMOD	B-DNA
T31	I-Entity	730	731	'	'	I-NP	SYM	I-DNA	31	NMOD	I-DNA
T31	I-Entity	731	732	-	-	I-NP	HYPH	I-DNA	31	NMOD	I-DNA
T31	I-Entity	732	742	regulatory	regulatory	I-NP	JJ	I-DNA	31	NMOD	I-DNA
T31	I-Entity	743	749	region	region	I-NP	NN	I-DNA	25	PMOD	I-DNA
O	O	750	752	of	of	B-PP	IN	O	31	NMOD	O
O	O	753	756	the	the	B-NP	DT	O	38	NMOD	O
T11	B-Protein	757	759	IL	IL	I-NP	NN	B-DNA	38	NMOD	B-DNA
T11	I-Protein	759	760	-	-	B-NP	HYPH	I-DNA	38	NMOD	I-DNA
T11	I-Protein	760	762	2R	2R	I-NP	NN	I-DNA	38	NMOD	I-DNA
T11	I-Protein	763	768	alpha	alpha	I-NP	NN	I-DNA	38	NMOD	I-DNA
O	O	769	773	gene	gene	I-NP	NN	I-DNA	32	PMOD	I-DNA
O	O	773	774	.	.	O	.	O	9	P	O

O	O	775	777	To	To	B-VP	TO	O	2	VMOD	O
O	O	778	785	dissect	dissect	I-VP	VB	O	20	VMOD	O
O	O	786	789	the	the	B-NP	DT	O	5	NMOD	O
O	O	790	799	molecular	molecular	I-NP	JJ	O	5	NMOD	O
O	O	800	805	basis	basis	I-NP	NN	O	2	OBJ	O
O	O	806	809	for	for	B-PP	IN	O	5	NMOD	O
O	O	810	813	the	the	B-NP	DT	O	10	NMOD	O
O	O	814	823	unusually	unusually	I-NP	RB	O	9	AMOD	O
O	O	824	834	persistent	persistent	I-NP	JJ	O	10	NMOD	O
O	O	835	848	transcription	transcription	I-NP	NN	O	6	PMOD	O
O	O	849	851	of	of	B-PP	IN	O	10	NMOD	O
O	O	852	855	the	the	B-NP	DT	O	17	NMOD	O
T12	B-Protein	856	858	IL	IL	I-NP	NN	B-DNA	17	NMOD	B-DNA
T12	I-Protein	858	859	-	-	B-NP	HYPH	I-DNA	17	NMOD	I-DNA
T12	I-Protein	859	861	2R	2R	I-NP	NN	I-DNA	17	NMOD	I-DNA
T12	I-Protein	862	867	alpha	alpha	I-NP	NN	I-DNA	17	NMOD	I-DNA
O	O	868	872	gene	gene	I-NP	NN	I-DNA	11	PMOD	I-DNA
O	O	872	873	,	,	O	,	O	20	P	O
O	O	874	876	we	we	B-NP	PRP	O	20	SUB	O
O	O	877	885	analyzed	analyze	B-VP	VBD	O	0	ROOT	O
O	O	886	893	nuclear	nuclear	B-NP	JJ	B-protein	25	NMOD	B-protein
T32	B-Entity	894	896	NF	NF	I-NP	NN	I-protein	25	NMOD	I-protein
T32	I-Entity	896	897	-	-	B-NP	HYPH	I-protein	25	P	I-protein
T32	I-Entity	897	902	kappa	kappa	I-NP	NN	I-protein	25	NMOD	I-protein
T32	I-Entity	903	904	B	B	I-NP	NN	I-protein	39	NMOD	I-protein
O	O	905	912	binding	bind	B-VP	VBG	O	25	NMOD	O
O	O	913	915	to	to	B-PP	TO	O	25	NMOD	O
O	O	916	917	a	a	B-NP	DT	O	35	NMOD	O
O	O	918	930	radiolabeled	radiolabele	I-NP	VBN	O	35	NMOD	O
T13	B-Protein	931	933	IL	IL	I-NP	NN	O	35	NMOD	O
T13	I-Protein	933	934	-	-	I-NP	HYPH	O	35	P	O
T13	I-Protein	934	936	2R	2R	I-NP	NN	O	35	NMOD	O
T13	I-Protein	937	942	alpha	alpha	I-NP	NN	O	35	NMOD	O
T33	B-Entity	943	948	kappa	kappa	I-NP	NN	O	35	NMOD	O
T33	I-Entity	949	950	B	B	I-NP	NN	O	27	PMOD	O
T33	I-Entity	950	951	-	-	B-NP	HYPH	O	39	P	O
T33	I-Entity	951	959	specific	specific	I-NP	JJ	O	39	NMOD	O
T33	I-Entity	960	975	oligonucleotide	oligonucleotide	I-NP	NN	O	39	NMOD	O
T33	I-Entity	976	981	probe	probe	I-NP	NN	O	20	OBJ	O
O	O	982	988	during	during	B-PP	IN	O	39	NMOD	O
O	O	989	992	the	the	B-NP	DT	O	43	NMOD	O
O	O	993	997	time	time	I-NP	NN	O	43	NMOD	O
O	O	998	1004	course	course	I-NP	NN	O	40	PMOD	O
O	O	1005	1007	of	of	B-PP	IN	O	43	NMOD	O
T14	B-Protein	1008	1011	CD2	CD2	B-NP	NN	B-protein	47	NMOD	B-protein
O	O	1012	1013	+	+	I-NP	CC	O	47	NMOD	O
T15	B-Protein	1014	1018	CD28	CD28	I-NP	NN	B-protein	48	NMOD	B-protein
O	O	1019	1029	activation	activation	I-NP	NN	O	44	PMOD	O
O	O	1029	1030	.	.	O	.	O	20	P	O

O	O	1031	1038	Resting	Rest	B-NP	VBG	O	6	NMOD	O
O	O	1039	1040	T	T	I-NP	NN	O	6	NMOD	O
O	O	1040	1041	-	-	I-NP	HYPH	O	6	NMOD	O
O	O	1041	1045	cell	cell	I-NP	NN	O	6	NMOD	O
O	O	1046	1053	nuclear	nuclear	I-NP	JJ	O	6	NMOD	O
O	O	1054	1062	extracts	extract	I-NP	NNS	O	7	SUB	O
O	O	1063	1072	contained	contain	B-VP	VBD	O	0	ROOT	O
T16	B-Protein	1073	1077	KBF1	KBF1	B-NP	NN	B-protein	11	NMOD	B-protein
O	O	1077	1078	/	/	B-NP	SYM	O	11	NMOD	O
T17	B-Protein	1078	1081	p50	p50	I-NP	NN	B-protein	11	NMOD	B-protein
T34	B-Entity	1082	1091	homodimer	homodimer	I-NP	NN	I-protein	7	OBJ	I-protein
O	O	1091	1092	.	.	O	.	O	7	P	O

O	O	1093	1098	After	After	B-PP	IN	O	11	VMOD	O
O	O	1099	1110	stimulation	stimulation	B-NP	NN	O	1	PMOD	O
O	O	1110	1111	,	,	O	,	O	11	P	O
O	O	1112	1115	two	two	B-NP	CD	O	10	NMOD	O
O	O	1116	1119	new	new	I-NP	JJ	O	10	NMOD	O
T35	B-Entity	1120	1125	kappa	kappa	I-NP	NN	B-protein	7	NMOD	B-protein
T35	I-Entity	1126	1127	B	B	I-NP	NN	I-protein	10	NMOD	I-protein
T35	I-Entity	1127	1128	-	-	B-NP	HYPH	I-protein	10	NMOD	I-protein
T35	I-Entity	1128	1136	specific	specific	I-NP	JJ	I-protein	10	NMOD	I-protein
T35	I-Entity	1137	1146	complexes	complex	I-NP	NNS	I-protein	11	SUB	I-protein
O	O	1147	1151	were	be	B-VP	VBD	O	0	ROOT	O
O	O	1152	1162	identified	identify	I-VP	VBN	O	11	VC	O
O	O	1163	1165	as	as	B-PP	IN	O	12	VMOD	O
O	O	1166	1168	NF	NF	B-NP	NN	B-protein	18	NMOD	B-protein
O	O	1168	1169	-	-	B-NP	HYPH	I-protein	18	P	I-protein
O	O	1169	1174	kappa	kappa	I-NP	NN	I-protein	18	NMOD	I-protein
O	O	1175	1176	B	B	I-NP	NN	I-protein	18	NMOD	I-protein
T18	B-Protein	1177	1180	p50	p50	I-NP	NN	I-protein	21	NMOD	I-protein
O	O	1180	1181	-	-	B-NP	HYPH	O	21	NMOD	O
T19	B-Protein	1181	1184	p65	p65	I-NP	NN	B-protein	21	NMOD	B-protein
T36	B-Entity	1185	1196	heterodimer	heterodimer	I-NP	NN	I-protein	27	NMOD	I-protein
O	O	1197	1200	and	and	O	CC	O	27	NMOD	O
O	O	1201	1209	putative	putative	B-NP	JJ	O	27	NMOD	O
T20	B-Protein	1210	1211	c	c	I-NP	NN	B-protein	27	NMOD	B-protein
T20	I-Protein	1211	1212	-	-	B-NP	HYPH	I-protein	27	NMOD	I-protein
T20	I-Protein	1212	1215	Rel	Rel	I-NP	NN	I-protein	27	NMOD	I-protein
T37	B-Entity	1216	1225	homodimer	homodimer	I-NP	NN	I-protein	31	NMOD	I-protein
O	O	1226	1228	or	or	I-NP	CC	O	31	NMOD	O
T21	B-Protein	1229	1230	c	c	I-NP	NN	B-protein	31	NMOD	B-protein
T21	I-Protein	1230	1231	-	-	B-NP	HYPH	I-protein	31	P	I-protein
T21	I-Protein	1231	1234	Rel	Rel	I-NP	NN	I-protein	34	NMOD	I-protein
O	O	1234	1235	-	-	B-NP	HYPH	O	34	NMOD	O
T22	B-Protein	1235	1238	p65	p65	I-NP	NN	B-protein	34	NMOD	B-protein
T38	B-Entity	1239	1250	heterodimer	heterodimer	I-NP	NN	I-protein	13	PMOD	I-protein
O	O	1250	1251	.	.	O	.	O	11	P	O

O	O	1252	1256	Both	Both	B-NP	DT	O	3	NMOD	O
O	O	1257	1266	inducible	inducible	I-NP	JJ	O	3	NMOD	O
O	O	1267	1276	complexes	complex	I-NP	NNS	O	4	SUB	O
O	O	1277	1286	persisted	persist	B-VP	VBD	O	0	ROOT	O
O	O	1287	1290	for	for	B-PP	IN	O	4	VMOD	O
O	O	1291	1293	at	at	B-NP	IN	O	9	NMOD	O
O	O	1294	1299	least	least	I-NP	JJS	O	6	AMOD	O
O	O	1300	1301	3	3	I-NP	CD	O	6	AMOD	O
O	O	1302	1307	weeks	week	I-NP	NNS	O	5	PMOD	O
O	O	1307	1308	.	.	O	.	O	4	P	O

O	O	1309	1314	Their	Their	B-NP	PRP$	O	3	NMOD	O
O	O	1315	1323	relative	relative	I-NP	JJ	O	3	NMOD	O
O	O	1324	1330	levels	level	I-NP	NNS	O	4	SUB	O
O	O	1331	1335	were	be	B-VP	VBD	O	0	ROOT	O
O	O	1336	1340	very	very	B-ADJP	RB	O	6	AMOD	O
O	O	1341	1348	similar	similar	I-ADJP	JJ	O	4	PRD	O
O	O	1349	1352	for	for	B-PP	IN	O	6	AMOD	O
O	O	1353	1356	the	the	B-NP	DT	O	9	NMOD	O
O	O	1357	1365	duration	duration	I-NP	NN	O	7	PMOD	O
O	O	1366	1368	of	of	B-PP	IN	O	9	NMOD	O
O	O	1369	1382	proliferation	proliferation	B-NP	NN	O	10	PMOD	O
O	O	1382	1383	.	.	O	.	O	4	P	O

O	O	1384	1386	In	In	B-PP	IN	O	8	VMOD	O
O	O	1387	1395	parallel	parallel	B-NP	NN	O	1	PMOD	O
O	O	1395	1396	,	,	O	,	O	8	P	O
T23	B-Protein	1397	1400	CD2	CD2	B-NP	NN	B-protein	6	NMOD	B-protein
O	O	1401	1402	+	+	O	CC	O	6	NMOD	O
T24	B-Protein	1403	1407	CD28	CD28	B-NP	NN	B-protein	7	NMOD	B-protein
O	O	1408	1418	activation	activation	I-NP	NN	O	8	SUB	O
O	O	1419	1428	triggered	trigger	B-VP	VBD	O	0	ROOT	O
O	O	1429	1430	a	a	B-NP	DT	O	13	NMOD	O
O	O	1431	1442	significant	significant	I-NP	JJ	O	13	NMOD	O
O	O	1443	1456	intracellular	intracellular	I-NP	JJ	O	13	NMOD	O
O	O	1457	1462	thiol	thiol	I-NP	NN	O	13	NMOD	O
O	O	1463	1471	decrease	decrease	I-NP	NN	O	8	OBJ	O
O	O	1471	1472	,	,	O	,	O	8	P	O
O	O	1473	1483	suggesting	suggest	B-VP	VBG	O	8	VMOD	O
O	O	1484	1488	that	that	B-SBAR	IN	O	15	VMOD	O
O	O	1489	1495	oxygen	oxygen	B-NP	NN	O	18	NMOD	O
O	O	1496	1504	radicals	radical	I-NP	NNS	O	19	SUB	O
O	O	1505	1508	are	be	B-VP	VBP	O	16	SBAR	O
O	O	1509	1517	involved	involve	I-VP	VBN	O	19	VC	O
O	O	1518	1520	in	in	B-PP	IN	O	20	VMOD	O
O	O	1521	1524	the	the	B-NP	DT	O	24	NMOD	O
O	O	1525	1534	signaling	signaling	I-NP	NN	O	24	NMOD	O
O	O	1535	1542	pathway	pathway	I-NP	NN	O	21	PMOD	O
O	O	1543	1545	of	of	B-PP	IN	O	24	NMOD	O
O	O	1546	1554	adhesion	adhesion	B-NP	NN	B-protein	27	NMOD	B-protein
O	O	1555	1564	molecules	molecule	I-NP	NNS	I-protein	25	PMOD	I-protein
O	O	1564	1565	.	.	O	.	O	8	P	O

O	O	1566	1573	Finally	Finally	B-ADVP	RB	O	30	VMOD	O
O	O	1573	1574	,	,	O	,	O	30	P	O
O	O	1575	1585	micromolar	micromolar	B-NP	JJ	O	4	NMOD	O
O	O	1586	1593	amounts	amount	I-NP	NNS	O	30	SUB	O
O	O	1594	1596	of	of	B-PP	IN	O	4	NMOD	O
O	O	1597	1608	pyrrolidine	pyrrolidine	B-NP	NN	O	7	NMOD	O
O	O	1609	1624	dithiocarbamate	dithiocarbamate	I-NP	NN	O	12	NMOD	O
O	O	1624	1625	,	,	O	,	O	12	P	O
O	O	1626	1628	an	an	B-NP	DT	O	12	NMOD	O
O	O	1629	1635	oxygen	oxygen	I-NP	NN	O	11	AMOD	O
O	O	1636	1643	radical	radical	I-NP	NN	O	12	NMOD	O
O	O	1644	1653	scavenger	scavenger	I-NP	NN	O	5	PMOD	O
O	O	1654	1658	that	that	B-NP	WDT	O	12	NMOD	O
O	O	1659	1670	efficiently	efficiently	B-ADVP	RB	O	15	VMOD	O
O	O	1671	1678	blocked	block	B-VP	VBD	O	13	SBAR	O
O	O	1679	1682	the	the	B-NP	DT	O	18	NMOD	O
O	O	1683	1690	nuclear	nuclear	I-NP	JJ	O	18	NMOD	O
O	O	1691	1701	appearance	appearance	I-NP	NN	O	15	OBJ	O
O	O	1702	1704	of	of	B-PP	IN	O	18	NMOD	O
T39	B-Entity	1705	1707	NF	NF	B-NP	NN	B-protein	23	NMOD	B-protein
T39	I-Entity	1707	1708	-	-	B-NP	HYPH	I-protein	23	NMOD	I-protein
T39	I-Entity	1708	1713	kappa	kappa	I-NP	NN	I-protein	23	NMOD	I-protein
T39	I-Entity	1714	1715	B	B	I-NP	NN	I-protein	19	PMOD	I-protein
O	O	1716	1718	in	in	B-PP	IN	O	18	NMOD	O
O	O	1719	1720	T	T	B-NP	NN	B-cell_type	27	NMOD	B-cell_type
O	O	1720	1721	-	-	B-NP	HYPH	I-cell_type	27	NMOD	I-cell_type
O	O	1721	1732	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	24	PMOD	I-cell_type
O	O	1732	1733	,	,	O	,	O	4	P	O
O	O	1734	1738	also	also	B-ADVP	RB	O	30	VMOD	O
O	O	1739	1748	inhibited	inhibit	B-VP	VBD	O	0	ROOT	O
T25	B-Protein	1749	1751	IL	IL	B-NP	NN	B-protein	34	NMOD	B-protein
T25	I-Protein	1751	1752	-	-	B-NP	HYPH	I-protein	31	NMOD	I-protein
T25	I-Protein	1752	1753	2	2	I-NP	CD	I-protein	34	NMOD	I-protein
O	O	1754	1763	secretion	secretion	I-NP	NN	O	48	NMOD	O
O	O	1763	1764	,	,	O	,	O	48	P	O
T26	B-Protein	1765	1767	IL	IL	B-NP	NN	B-protein	42	NMOD	B-protein
T26	I-Protein	1767	1768	-	-	B-NP	HYPH	O	42	NMOD	O
T26	I-Protein	1768	1770	2R	2R	I-NP	NN	O	42	NMOD	O
T26	I-Protein	1771	1776	alpha	alpha	I-NP	NN	O	42	NMOD	O
O	O	1777	1781	cell	cell	I-NP	NN	O	42	NMOD	O
O	O	1782	1789	surface	surface	I-NP	NN	O	42	NMOD	O
O	O	1790	1800	expression	expression	I-NP	NN	O	48	NMOD	O
O	O	1800	1801	,	,	O	,	O	48	P	O
O	O	1802	1805	and	and	O	CC	O	48	NMOD	O
O	O	1806	1807	T	T	B-NP	NN	O	48	NMOD	O
O	O	1807	1808	-	-	I-NP	HYPH	O	48	NMOD	O
O	O	1808	1812	cell	cell	I-NP	NN	O	48	NMOD	O
O	O	1813	1826	proliferation	proliferation	I-NP	NN	O	30	OBJ	O
O	O	1826	1827	.	.	O	.	O	30	P	O

O	O	1828	1836	Together	Together	B-ADVP	RB	O	5	VMOD	O
O	O	1836	1837	,	,	O	,	O	5	P	O
O	O	1838	1843	these	these	B-NP	DT	O	4	NMOD	O
O	O	1844	1851	results	result	I-NP	NNS	O	5	SUB	O
O	O	1852	1859	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	1860	1864	that	that	B-SBAR	IN	O	5	VMOD	O
T40	B-Entity	1865	1867	NF	NF	B-NP	NN	B-protein	10	NMOD	B-protein
T40	I-Entity	1867	1868	-	-	B-NP	HYPH	I-protein	10	NMOD	I-protein
T40	I-Entity	1868	1873	kappa	kappa	I-NP	NN	I-protein	10	NMOD	I-protein
T40	I-Entity	1874	1875	B	B	I-NP	NN	I-protein	11	SUB	I-protein
O	O	1876	1881	plays	play	B-VP	VBZ	O	6	SBAR	O
O	O	1882	1884	an	an	B-NP	DT	O	14	NMOD	O
O	O	1885	1894	important	important	I-NP	JJ	O	14	NMOD	O
O	O	1895	1899	role	role	I-NP	NN	O	11	OBJ	O
O	O	1900	1902	in	in	B-PP	IN	O	11	VMOD	O
O	O	1903	1907	long	long	B-NP	JJ	O	19	NMOD	O
O	O	1907	1908	-	-	I-NP	HYPH	O	19	NMOD	O
O	O	1908	1912	term	term	I-NP	NN	O	19	NMOD	O
O	O	1913	1923	activation	activation	I-NP	NN	O	15	PMOD	O
O	O	1924	1926	of	of	B-PP	IN	O	19	NMOD	O
O	O	1927	1932	human	human	B-NP	JJ	B-cell_type	25	NMOD	B-cell_type
O	O	1933	1940	primary	primary	I-NP	JJ	I-cell_type	25	NMOD	I-cell_type
O	O	1941	1942	T	T	I-NP	NN	I-cell_type	25	NMOD	I-cell_type
O	O	1942	1943	-	-	O	HYPH	I-cell_type	25	NMOD	I-cell_type
O	O	1943	1954	lymphocytes	lymphocyte	B-NP	NNS	I-cell_type	20	PMOD	I-cell_type
O	O	1955	1958	via	via	B-PP	IN	O	19	NMOD	O
T27	B-Protein	1959	1962	CD2	CD2	B-NP	NN	B-protein	29	NMOD	B-protein
O	O	1963	1964	+	+	I-NP	CC	O	29	NMOD	O
T28	B-Protein	1965	1969	CD28	CD28	I-NP	NN	B-protein	26	PMOD	B-protein
O	O	1969	1970	.	.	O	.	O	5	P	O
